Nvidia’s Q3 FY27: The Reassurance Before the Storm
Nvidia faces allegations over China and Southeast Asia sales, financial reporting and governance ahead of Q3 FY27 results.
Nvidia faces allegations over China and Southeast Asia sales, financial reporting and governance ahead of Q3 FY27 results.
@evfcfaddict @alluvialcapital $BWEL will work eventually
Tom likes the stock. $MKL adding >10% buyback auth, now ~15% buyback auth outstanding.
Target Posts Strongest Sales Growth in Years as Focus on New Products, Value Pays Off $TGT
TJX Raises Full-Year Outlook, Expects Sales Trends to Accelerate Through Holiday Season $TJX
Cal-Maine Foods to Cull 1.76 Million Birds After Florida Facility Tests Positive for Bird Flu $CALM
Nvidia faced China workaround enforcement concerns as technology fell 6%; energy rose 4.5%, while the company raised eFY28 revenue growth…
MiniMed's 15.8% Q1 organic growth and 20% U.S. pump-volume increase support a product-cycle recovery as split-off selling fades.
Nvidia reported $115.8 billion in Q3 revenue, up 103%, and guided $130 billion, while Jensen Huang’s resignation left Colette Kress as…
Pfizer’s Q3 revenue reached $16.58 billion, launched and acquired products grew 32%, and FY26 guidance rose to $62 billion to $64 billion.
NVIDIA’s fiscal third-quarter 2027 results are its first earnings report since Jensen Huang’s resignation as CEO.
UFP Industries trades near its 2022 price despite EPS falling 62%; a $95–$105 valuation assumes $6.30 normal-year EPS, with freight and…
Nvidia reported $115.8 billion in Q3 revenue, up 103%, and raised its fiscal 2028 growth outlook to 75% as interim CEO Colette Kress…
Century Aluminum (CENX) could benefit from U.S. tariffs, Midwest aluminum premiums and constrained global supply, with the stock trading…
Figma grew Q3 revenue 43% to $391.4 million, raised FY2026 guidance to nearly $1.5 billion and guided Q4 above consensus despite the stock…
Nvidia raised its fiscal 2028 growth outlook, but shares reversed as investors focused on uncertainty beyond January 2028.
SLS · short SELLAS Life Sciences Group faces a short case arguing that even a strong clinical outcome does not support its current valuation.
SK Hynix's U.S. ADR begins trading as SKHYV before switching to SKHY, with HBM demand expected to outstrip supply as AI server memory…
U-Haul’s pandemic-era fleet purchases at inflated prices now drive higher depreciation and disposal losses as truck and van prices…
Emerging Moats returned 30.57% since July 2024 versus 43.37% for the S&P 500, with Oscar Health accounting for half its gains and a…
Copart’s returning CEO Jay Adair plans to restart European expansion and build domestic whole-car sales on its global buyer network amid…
DoubleU’s $11.25-per-share bid for DoubleDown Interactive values its operating business at 0.25-0.7x EBITDA; minority holders can block it…
High Bandwidth Flash stacks NAND beside GPUs to deliver HBM4-class bandwidth and roughly 10 times the capacity for AI inference decode.
JD, Alibaba and Douyin are assessed for their competitive threat to PDD, with a specific investment stance on JD.
Palantir’s forward-deployed engineering model underpins its AI software growth, but AWS, Microsoft and AI labs are copying it at scale as…
Nvidia's Kyber NVL144 midplane must replace 5,000 copper cables with roughly 20,000 PCB connections, driving manufacturing and signal-loss…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.